REGN – Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

REGN

$726.47

Name : Regeneron Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $0.00000000000000

EPSttm : 40.44

Regeneron Pharmaceuticals, Inc.

$726.47

1.19%

$8.73

REGN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.55

Margin Of Safety %

Put/Call OI Ratio

0.83

EPS Next Q Diff

EPS Last/This Y

9.79

EPS This/Next Y

-3.47

Price

735.2

Target Price

858.12

Analyst Recom

1.9

Performance Q

13.14

Upside

21.1%

Beta

0.14

Ticker: REGN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-08	REGN	810.31	0.78	1.72	37935
2026-09-09	REGN	807.77	0.79	0.66	38456
2026-09-10	REGN	793.57	0.79	0.95	38777
2026-09-11	REGN	781.51	0.79	0.42	39185
2026-09-14	REGN	794.74	0.79	0.50	38683
2026-09-15	REGN	773.93	0.79	0.88	38868
2026-09-16	REGN	774.94	0.80	3.00	39382
2026-09-17	REGN	789.43	0.80	0.84	39499
2026-09-18	REGN	785.03	0.80	1.62	39765
2026-09-21	REGN	798.33	0.83	0.66	33340
2026-09-22	REGN	803.86	0.82	0.23	33918
2026-09-23	REGN	801.35	0.81	0.95	34249
2026-09-24	REGN	795.8	0.82	0.59	34494
2026-09-25	REGN	787.96	0.82	0.84	34659
2026-09-28	REGN	752.23	0.81	0.42	34185
2026-09-29	REGN	750.53	0.83	0.74	34614
2026-09-30	REGN	759.27	0.83	0.79	35230
2026-10-01	REGN	734.65	0.83	1.13	35347
2026-10-02	REGN	735.64	0.83	0.49	35650
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-08	REGN	810.46	35.2	-441.3	53.55
2026-09-09	REGN	807.77	35.2	-348.9	53.55
2026-09-10	REGN	793.29	34.8	-425.4	53.54
2026-09-11	REGN	781.52	34.8	-409.9	53.54
2026-09-14	REGN	793.57	34.8	-251.7	53.80
2026-09-15	REGN	773.65	34.8	-464.9	53.80
2026-09-16	REGN	773.65	34.8	-464.9	53.80
2026-09-17	REGN	789.31	34.8	-233.3	53.80
2026-09-18	REGN	784.91	34.8	-362.7	53.80
2026-09-21	REGN	798.31	34.8	-242.9	53.80
2026-09-22	REGN	803.86	34.8	-295.4	53.80
2026-09-23	REGN	801.86	34.8	-345.8	53.80
2026-09-24	REGN	795.60	34.8	-373.1	53.80
2026-09-25	REGN	788.05	34.8	-384.9	54.10
2026-09-28	REGN	752.24	34.8	-570.2	54.10
2026-09-29	REGN	750.43	34.8	-345.3	54.10
2026-09-30	REGN	758.08	34.8	-279.7	54.10
2026-10-01	REGN	734.60	34.8	246.0	54.10
2026-10-02	REGN	735.20	34.8	250.8	54.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-08	REGN	-0.11	-0.39	2.42
2026-09-09	REGN	-0.11	-0.39	2.42
2026-09-10	REGN	-0.11	-0.39	2.42
2026-09-11	REGN	-0.11	-0.39	2.58
2026-09-14	REGN	-0.11	-0.45	2.58
2026-09-15	REGN	-0.11	-0.45	2.58
2026-09-16	REGN	-0.11	-0.45	2.58
2026-09-17	REGN	-0.11	-0.45	2.58
2026-09-18	REGN	-0.11	-0.45	2.58
2026-09-21	REGN	-0.11	-0.44	2.58
2026-09-23	REGN	-0.11	-0.44	2.58
2026-09-24	REGN	-0.11	-0.44	2.58
2026-09-25	REGN	-0.11	-0.44	2.55
2026-09-28	REGN	-0.11	-0.38	2.55
2026-09-29	REGN	-0.11	-0.38	2.55
2026-09-30	REGN	-0.11	-0.38	2.55
2026-10-01	REGN	-0.11	-0.38	2.55
2026-10-02	REGN	-0.11	-0.38	2.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

12.53

Avg. EPS Est. Current Quarter

15.94

Avg. EPS Est. Next Quarter

15.53

Insider Transactions

-0.11

Institutional Transactions

-0.38

Beta

0.14

Average Sales Estimate Current Quarter

4537

Average Sales Estimate Next Quarter

4628

Fair Value

1058.51

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

39.3

Max Drawdown 5-Year %

-59.7

Target Price

858.12

P/E

18.17

Forward P/E

11.89

PEG

0.76

P/S

4.87

P/B

2.4

P/Free Cash Flow

20.13

EPS

40.46

Average EPS Est. Cur. Y

54.1

EPS Next Y. (Est.)

50.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

27.86

Relative Volume

0.8

Return on Equity vs Sector %

-12.5

Return on Equity vs Industry %

7.2

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.55

EBIT Estimation

250.8

◆ REGN Healthcare

$735.20

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

25/25

Volume

7/15

Valuation

16/20

TP/AR

1/10

Options

4/10

RSI

34.9

Range 1M

8.3%

Sup Dist

2.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

19/30

Estimates

6/20

Inst/Vol

3/15

Options

7/10

EPS Yr

25.3%

EPS NY

11.4%

52W%

61.6%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +42.3% upside

Quality

20/30

Valuation

23/30

Growth

14/25

Stability

9/10

LT Trend

0/5

Upside

+42.3%

Quality

MoS

44%

REGN — P/E HistoricalBiotechnology

REGN

Latest News

—

Caricamento notizie per REGN…

stock quote shares REGN – Regeneron Pharmaceuticals, Inc. Stock Price stock today

news today REGN – Regeneron Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch REGN – Regeneron Pharmaceuticals, Inc. yahoo finance google finance

stock history REGN – Regeneron Pharmaceuticals, Inc. invest stock market

stock prices REGN premarket after hours

ticker REGN fair value insiders trading

REGN – Regeneron Pharmaceuticals, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: REGN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y